CN Patent
CN101623250B — 一种左乙拉西坦药物组合物及其制备方法
Assigned to AVENTIS PHARMA (HAINAN) Co.,Ltd. · Expires 2013-02-27 · 13y expired
What this patent protects
本发明公开了一种含有左乙拉西坦的注射用药物组合物及其制备方法,该药物组合物包括活性成分左乙拉西坦和其他辅料成分。该药物组合物主要用于癫痫的治疗。
USPTO Abstract
本发明公开了一种含有左乙拉西坦的注射用药物组合物及其制备方法,该药物组合物包括活性成分左乙拉西坦和其他辅料成分。该药物组合物主要用于癫痫的治疗。
Drugs covered by this patent
- Keppra (levetiracetam) · Generic (originally UCB Pharma)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.